00 test page

We use AlzWIN for quick brain health checks in seniors. It is effective in identifying high-risk dementia cases with minimal extra effort.

Memory Clinic Director

Some elderly individuals are hesitant to undergo dementia diagnostic tests with healthcare professionals. However, AlzWIN can be administered with minimal contact, making it an excellent initial assessment tool. If AlzWIN detects a high risk, they can then advance to an official diagnostic test. It is a great tool

Occupational Therapist

I took AlzWIN because I felt I was becoming forgetful. I appreciated having the option to decide whether to report my results before proceeding further

Test Participant

– Some causes of dementia are treatable if detected early

– If Alzheimer’s is the cause, early diagnosis offers the following benefits:

Access to treatment options

  • New treatments like donanemab and lecanemab help reduce cognitive and functional decline in early Alzheimer’s by targeting beta-amyloid
  • Additionally, there are various medications available that can help temporarily alleviate symptoms such as memory loss and confusion
  • Early diagnosis enables individuals to benefit from these various treatments at the appropriate time.

An opportunity to participate
in clinical trials

  • Early diagnosis can secure opportunities to participate in clinical trials for new dementia-related drugs and gain access to various treatment options.

A chance to prioritize your health

  • Early diagnosis enables individuals to make timely lifestyle changes like managing blood pressure, quitting smoking, exercising, and staying mentally and socially active, delaying cognitive decline

AlzWINの導入拡大

2022年下期

メモリークリニックの数

1

特定された
高リスク症例数

66

2023年上期

メモリークリニックの数

3

特定された
高リスク症例数

96

2023年下期

メモリークリニックの数

7

特定された
高リスク症例数

1,744

2024年上期

メモリークリニックの数

47

特定された
高リスク症例数

6,700

AlzWINの導入拡大

AlzWINアルゴリズムデータの精度（認知症VS正常君）

High Risk Found
Memory Clinic

Based on the clinical trial at a clinic

Our Address:

Korea Office: 종암로 18 바이오 혁신 커뮤니티 센터 301호
US Office: 1730 Minor Ave Suite 1050, Seattle, WA 98101

Phone Line:

TEL. No. 02-6959-7933

Email Address:

info@sevenptone.com

    Our Address

    Korea Office

    종암로 18 바이오 혁신 커뮤니티 센터 301호

    US Office

    1730 Minor Ave Suite 1050, Seattle, WA 98101

    Phone Line

    TEL. No. 02-6959-7933

    Email Address

    info@sevenptone.com
    복사되었습니다

    Medical Benefit

    Read More

    Emotional and social benefits

    Read More

    More time to plan for the future

    Read More

    Cost saving

    Read More

    Accuracy on AlzWIN Algorithm Data(Alzheimer's Disease VS Normal)

    Alzheimer's Disease
    Normal

    Based on the clinical trial at a clinic

    AlzWIN is
    Accurate

    • Confirmed thru numerous clinical studies, third-party tests, peer-reviewed publications, and real-world use
    • The latest clinical trial effectively and accurately identified individuals with cognitive decline
    • Confirmed by numerous clinical studies, third-party tests, peer-reviewed publications, and real-world use
    • The latest clinical trial effectively and accurately identified individuals with cognitive decline